Intech Biopharm Corporation (TPEX:6461)

Intech Biopharm Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	207.19	198.65	77.73	64.82	220.48	204.69
Short-Term Investments	-	60	520	310	115	100
Cash & Short-Term Investments	207.19	258.65	597.73	374.82	335.48	304.69
Cash Growth	-65.91%	-56.73%	59.47%	11.73%	10.11%	9.95%
Accounts Receivable	2.09	9.28	3.05	3.67	15.04	4.87
Other Receivables	10.05	9.83	8.7	7.94	7.94	7.78
Receivables	12.14	19.11	11.74	11.6	22.98	12.65
Inventory	112.17	63.86	41.53	51.82	59.87	56.97
Prepaid Expenses	66.24	68.65	43.62	40.7	33.74	35.46
Other Current Assets	0.01	0.06	0.41	0.13	4.26	-
Total Current Assets	397.75	410.32	695.02	479.06	456.33	409.77
Property, Plant & Equipment	1,581	1,885	1,900	2,009	2,090	2,178
Other Intangible Assets	3.6	3.86	4.88	4.8	4.62	4.75
Long-Term Deferred Tax Assets	24.77	24.77	24.77	24.77	24.77	24.77
Other Long-Term Assets	365.08	71.69	86.15	33.17	26.26	4.31
Total Assets	2,372	2,396	2,711	2,551	2,602	2,621
Accounts Payable	4.34	9.82	0.31	1.33	2.4	1.02
Accrued Expenses	27.71	28.82	19.24	23.71	20.82	19.56
Short-Term Debt	80	-	-	-	-	30
Current Portion of Long-Term Debt	249.48	248.82	464.65	265.26	211.66	12.89
Current Unearned Revenue	80.86	81.18	78.54	78.31	78.99	81.21
Other Current Liabilities	3.71	18	5.99	5.23	9.35	9.86
Total Current Liabilities	446.11	386.64	568.73	373.82	323.22	154.52
Long-Term Debt	1,188	1,188	970.41	1,143	940.77	1,138
Long-Term Unearned Revenue	8.84	5.53	2.35	-	-	-
Other Long-Term Liabilities	1.77	1.72	1.74	1.54	-	-
Total Liabilities	1,644	1,582	1,543	1,519	1,264	1,293
Common Stock	1,379	1,379	1,374	1,170	1,163	1,007
Additional Paid-In Capital	19.41	19.76	286.16	195.15	481.32	574.58
Retained Earnings	-668.11	-579.76	-488.08	-327.88	-301.76	-250.37
Comprehensive Income & Other	-2.6	-5.16	-4.32	-5.13	-4.72	-2.7
Shareholders' Equity	728.13	814.28	1,168	1,032	1,338	1,329
Total Liabilities & Equity	2,372	2,396	2,711	2,551	2,602	2,621
Total Debt	1,517	1,436	1,435	1,409	1,152	1,181
Net Cash (Debt)	-1,310	-1,178	-837.33	-1,034	-816.94	-876.4
Net Cash Per Share	-9.53	-8.58	-6.95	-8.90	-8.03	-8.74
Filing Date Shares Outstanding	137.94	137.94	137.41	116.96	116.28	100.73
Total Common Shares Outstanding	137.94	137.94	137.41	116.96	116.28	100.73
Working Capital	-48.37	23.68	126.3	105.24	133.11	255.25
Book Value Per Share	5.28	5.90	8.50	8.82	11.50	13.19
Tangible Book Value	724.53	810.42	1,163	1,027	1,333	1,324
Tangible Book Value Per Share	5.25	5.87	8.46	8.78	11.46	13.14
Land	629.9	919.87	919.87	950.72	950.72	950.72
Buildings	790.43	791.07	790.24	798.32	810.2	809.13
Machinery	733.12	724.87	657.12	645.9	633.52	616.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.